Annual EBITDA
-$41.44 M
+$52.09 M+55.70%
31 December 2023
Summary:
Elevation Oncology annual earnings before interest, taxes, depreciation & amortization is currently -$41.44 million, with the most recent change of +$52.09 million (+55.70%) on 31 December 2023. During the last 3 years, it has fallen by -$24.17 million (-140.05%). ELEV annual EBITDA is now -140.05% below its all-time high of -$17.26 million, reached on 31 December 2020.ELEV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$13.22 M
-$2.27 M-20.67%
30 September 2024
Summary:
Elevation Oncology quarterly earnings before interest, taxes, depreciation & amortization is currently -$13.22 million, with the most recent change of -$2.27 million (-20.67%) on 30 September 2024. Over the past year, it has dropped by -$2.31 million (-21.20%). ELEV quarterly EBITDA is now -575.04% below its all-time high of -$1.96 million, reached on 31 March 2020.ELEV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$43.11 M
-$2.31 M-5.67%
30 September 2024
Summary:
Elevation Oncology TTM earnings before interest, taxes, depreciation & amortization is currently -$43.11 million, with the most recent change of -$2.31 million (-5.67%) on 30 September 2024. Over the past year, it has increased by +$6.78 million (+13.59%). ELEV TTM EBITDA is now -2100.82% below its all-time high of -$1.96 million, reached on 31 March 2020.ELEV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELEV EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.7% | -21.2% | +13.6% |
| 3 y3 years | -140.1% | -7.7% | -37.8% |
| 5 y5 years | - | - | - |
ELEV EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -140.1% | +55.7% | -45.8% | +65.7% | -37.8% | +53.9% |
| 5 y | 5 years | -140.1% | +55.7% | -575.0% | +65.7% | -2100.8% | +53.9% |
| alltime | all time | -140.1% | +55.7% | -575.0% | +65.7% | -2100.8% | +53.9% |
Elevation Oncology EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$13.22 M(+20.7%) | -$43.11 M(+5.7%) |
| June 2024 | - | -$10.96 M(+11.2%) | -$40.80 M(+2.9%) |
| Mar 2024 | - | -$9.86 M(+8.7%) | -$39.67 M(-4.3%) |
| Dec 2023 | -$41.44 M(-55.7%) | -$9.07 M(-16.9%) | -$41.44 M(-17.0%) |
| Sept 2023 | - | -$10.91 M(+11.1%) | -$49.90 M(-35.6%) |
| June 2023 | - | -$9.82 M(-15.5%) | -$77.51 M(-11.7%) |
| Mar 2023 | - | -$11.63 M(-33.7%) | -$87.79 M(-6.1%) |
| Dec 2022 | -$93.53 M | -$17.53 M(-54.5%) | -$93.53 M(+9.2%) |
| Sept 2022 | - | -$38.52 M(+91.6%) | -$85.61 M(+44.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$20.11 M(+15.8%) | -$59.37 M(+34.0%) |
| Mar 2022 | - | -$17.36 M(+80.5%) | -$44.31 M(+38.3%) |
| Dec 2021 | -$32.03 M(+85.6%) | -$9.62 M(-21.6%) | -$32.03 M(+2.4%) |
| Sept 2021 | - | -$12.27 M(+142.9%) | -$31.28 M(+42.1%) |
| June 2021 | - | -$5.05 M(-0.6%) | -$22.02 M(+8.0%) |
| Mar 2021 | - | -$5.08 M(-42.7%) | -$20.38 M(+18.1%) |
| Dec 2020 | -$17.26 M | -$8.87 M(+194.6%) | -$17.26 M(+105.8%) |
| Sept 2020 | - | -$3.01 M(-11.9%) | -$8.39 M(+56.0%) |
| June 2020 | - | -$3.42 M(+74.5%) | -$5.38 M(+174.5%) |
| Mar 2020 | - | -$1.96 M | -$1.96 M |
FAQ
- What is Elevation Oncology annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Elevation Oncology?
- What is Elevation Oncology annual EBITDA year-on-year change?
- What is Elevation Oncology quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Elevation Oncology?
- What is Elevation Oncology quarterly EBITDA year-on-year change?
- What is Elevation Oncology TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Elevation Oncology?
- What is Elevation Oncology TTM EBITDA year-on-year change?
What is Elevation Oncology annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ELEV is -$41.44 M
What is the all time high annual EBITDA for Elevation Oncology?
Elevation Oncology all-time high annual earnings before interest, taxes, depreciation & amortization is -$17.26 M
What is Elevation Oncology annual EBITDA year-on-year change?
Over the past year, ELEV annual earnings before interest, taxes, depreciation & amortization has changed by +$52.09 M (+55.70%)
What is Elevation Oncology quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ELEV is -$13.22 M
What is the all time high quarterly EBITDA for Elevation Oncology?
Elevation Oncology all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$1.96 M
What is Elevation Oncology quarterly EBITDA year-on-year change?
Over the past year, ELEV quarterly earnings before interest, taxes, depreciation & amortization has changed by -$2.31 M (-21.20%)
What is Elevation Oncology TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ELEV is -$43.11 M
What is the all time high TTM EBITDA for Elevation Oncology?
Elevation Oncology all-time high TTM earnings before interest, taxes, depreciation & amortization is -$1.96 M
What is Elevation Oncology TTM EBITDA year-on-year change?
Over the past year, ELEV TTM earnings before interest, taxes, depreciation & amortization has changed by +$6.78 M (+13.59%)